EMEA-002462-PIP01-18

Key facts

Active substance
Telmisartan / indapamide
Therapeutic area
Cardiovascular diseases
Decision number
P/0024/2019
PIP number
EMEA-002462-PIP01-18
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
PRO.MED.CS a.s.

Tel.  +420 241013111
E-mail: promed@promedcs.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating